.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Cantor Fitzgerald
Baxter
Julphar
Queensland Health
Farmers Insurance
Colorcon
Dow
McKinsey
Covington

Generated: December 17, 2017

DrugPatentWatch Database Preview

MELOXICAM Drug Profile

« Back to Dashboard

When do Meloxicam patents expire, and what generic alternatives are available?

Meloxicam is a drug marketed by Anda Repository, Apotex Inc, Aurobindo Pharma, Breckenridge Pharm, Cipla Ltd, Corepharma, Cr Double Crane, Dr Reddys Labs Inc, Glenmark Generics, Lupin Pharms, Mylan, Puracap Pharm, Roxane, Strides Pharma, Sun Pharm Inds Inc, Taro, Teva Pharms, Unichem, Yabao Pharm, Yung Shin Pharm, and Zydus Pharms Usa. and is included in twenty-two NDAs.

The generic ingredient in MELOXICAM is meloxicam. There are twenty-two drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the meloxicam profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Yung Shin PharmMELOXICAMmeloxicamTABLET;ORAL077918-001Dec 7, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds IncMELOXICAMmeloxicamTABLET;ORAL077937-002Jul 19, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe
RoxaneMELOXICAMmeloxicamTABLET;ORAL077925-002Jul 19, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe
TaroMELOXICAMmeloxicamTABLET;ORAL078102-001Nov 7, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Strides PharmaMELOXICAMmeloxicamTABLET;ORAL077928-001May 13, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Anda RepositoryMELOXICAMmeloxicamTABLET;ORAL077935-001Jul 19, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe
Glenmark GenericsMELOXICAMmeloxicamTABLET;ORAL077932-002Jul 19, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
MylanMELOXICAMmeloxicamTABLET;ORAL077934-002Jul 20, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe
Yabao PharmMELOXICAMmeloxicamTABLET;ORAL077933-001Jul 19, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe
Breckenridge PharmMELOXICAMmeloxicamTABLET;ORAL077920-001Jul 19, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
US Army
Covington
Mallinckrodt
Citi
McKesson
Medtronic
UBS
Teva
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot